Synopsis
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 10ME...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 10MEQ
USFDA APPLICATION NUMBER - 19071
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 15ME...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 15MEQ
USFDA APPLICATION NUMBER - 19071
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 5MEQ
USFDA APPLICATION NUMBER - 19071
Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dr. Paul Lohmann GmbH & Co. KGaA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Bioplus Life Sciences
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CD Formulation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Esteem Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Neelkanth MineChem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Vasa Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Film Formers & Plasticizers
Lubricants & Glidants
Thickeners and Stabilizers
Fillers, Diluents & Binders
Taste Masking
Coating Systems & Additives
Solubilizers
Parenteral
Controlled & Modified Release
Emulsifying Agents
API Stability Enhancers
Granulation
Direct Compression
Chewable & Orodispersible Aids
Co-Processed Excipients
Soft Gelatin
Surfactant & Foaming Agents
Rheology Modifiers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
79
PharmaCompass offers a list of Potassium Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Potassium Citrate manufacturer or Potassium Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Potassium Citrate manufacturer or Potassium Citrate supplier.
PharmaCompass also assists you with knowing the Potassium Citrate API Price utilized in the formulation of products. Potassium Citrate API Price is not always fixed or binding as the Potassium Citrate Price is obtained through a variety of data sources. The Potassium Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Urocit K manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Urocit K, including repackagers and relabelers. The FDA regulates Urocit K manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Urocit K API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Urocit K manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Urocit K supplier is an individual or a company that provides Urocit K active pharmaceutical ingredient (API) or Urocit K finished formulations upon request. The Urocit K suppliers may include Urocit K API manufacturers, exporters, distributors and traders.
click here to find a list of Urocit K suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Urocit K DMF (Drug Master File) is a document detailing the whole manufacturing process of Urocit K active pharmaceutical ingredient (API) in detail. Different forms of Urocit K DMFs exist exist since differing nations have different regulations, such as Urocit K USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Urocit K DMF submitted to regulatory agencies in the US is known as a USDMF. Urocit K USDMF includes data on Urocit K's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Urocit K USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Urocit K suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Urocit K Drug Master File in Japan (Urocit K JDMF) empowers Urocit K API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Urocit K JDMF during the approval evaluation for pharmaceutical products. At the time of Urocit K JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Urocit K suppliers with JDMF on PharmaCompass.
A Urocit K CEP of the European Pharmacopoeia monograph is often referred to as a Urocit K Certificate of Suitability (COS). The purpose of a Urocit K CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Urocit K EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Urocit K to their clients by showing that a Urocit K CEP has been issued for it. The manufacturer submits a Urocit K CEP (COS) as part of the market authorization procedure, and it takes on the role of a Urocit K CEP holder for the record. Additionally, the data presented in the Urocit K CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Urocit K DMF.
A Urocit K CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Urocit K CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Urocit K suppliers with CEP (COS) on PharmaCompass.
A Urocit K written confirmation (Urocit K WC) is an official document issued by a regulatory agency to a Urocit K manufacturer, verifying that the manufacturing facility of a Urocit K active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Urocit K APIs or Urocit K finished pharmaceutical products to another nation, regulatory agencies frequently require a Urocit K WC (written confirmation) as part of the regulatory process.
click here to find a list of Urocit K suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Urocit K as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Urocit K API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Urocit K as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Urocit K and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Urocit K NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Urocit K suppliers with NDC on PharmaCompass.
Urocit K Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Urocit K GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Urocit K GMP manufacturer or Urocit K GMP API supplier for your needs.
A Urocit K CoA (Certificate of Analysis) is a formal document that attests to Urocit K's compliance with Urocit K specifications and serves as a tool for batch-level quality control.
Urocit K CoA mostly includes findings from lab analyses of a specific batch. For each Urocit K CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Urocit K may be tested according to a variety of international standards, such as European Pharmacopoeia (Urocit K EP), Urocit K JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Urocit K USP).
